Following the first virtual presentation at Interphex, Syntegon is now introducing its new filling machine for ready-to-use (RTU) nested syringes to the market.
ArisGlobal has announced that another pharmaceutical company has chosen LifeSphere Advanced Signals, a pharmacovigilance solution that leverages automation and AI-driven insights to streamline signal detection and management.
Phastar, a specialist biometrics & data science Contract Research Organisation (CRO), has been shortlisted in the ‘CRO Partnership of the Year’ category at the 2025 Citeline Awards for its collaboration with Medicines Development for Global Health.
Berry Global Healthcare to showcase latest technologies for patient-centric solutions participation at this year’s RDD (Respiratory Drug Delivery) Europe Conference, taking place at the Estoril Congress Centre, Portugal from 6-9 May.
Teckro has introduced its new Patient Data Return feature, providing patients with seamless access to their medical reports while giving sponsors greater oversight into engagement levels.
Infinitopes has announced that the UK Medicines and Healthcare products Regulatory Agency has granted Clinical Trial Application (CTA) approval for the first-in-human Phase I/IIa clinical trial of ITOP1, the company’s ‘off-the-shelf’ cancer vaccine.
Shilpa Medicare announces that Shilpa Pharma Lifesciences – a wholly owned subsidiary – has successfully passed a U.S. Food and Drug Administration (FDA) inspection for its Unit-2 facility in Raichur, India, with no 483 observations.
IFF Pharma Solutions has announced the launch of Low Nitrite METHOCEL hydroxypropyl methylcellulose (HPMC), a range of low nitrite cellulose ethers developed to reduce the risk of nitrosamine formation in finished pharmaceutical dosages.
Berry Global’s presence at this year’s Maghreb Pharma Expo highlights the company’s commitment to supporting growth in emerging healthcare markets across North Africa.
